$17.60
-0.94-5.07%
Last update: Nov 5, 3:36 PM
Dyne Therapeutics Inc
DYNNASDAQ
Dyne Therapeutics (DYN) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.88 | $-0.75 | $-0.77 | $-0.75 |
| Actual | $-1.06 | $-1.08 | $-0.73 | $-0.76 |
| Surprise | -20.4% | -44.0% | +5.19% | -1.33% |
| Revenue | ||||
| Estimate | — | — | — | — |
| Actual | $0 | $0 | $0 | $0 |
| Surprise | — | — | — | — |
| Metric | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|
| Earnings Per Share (Non-GAAP) | |||
| Consensus | $-0.90 | $-0.89 | $-0.85 |
| Revenue | |||
| Consensus | — | — | — |
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | Nov 5, 2026 | $-1.06 | $-0.88 | -20.4 % |
| Q2 | Jul 29, 2026 | $-1.08 | $-0.75 | -44.0 % |
| Q1 | May 11, 2026 | $-0.73 | $-0.77 | 5.19 % |
| Q4 | Mar 2, 2026 | $-0.76 | $-0.75 | -1.33 % |
